Oncogenesis

Oncogenesis refers to the process of cancer development, including the initiation, progression, and metastasis of cancer cells. Genomics and epigenomics are powerful tools for studying the molecular mechanisms of cancer development. Recent research has focused on using these techniques to identify new cancer drivers, such as mutations in oncogenes and tumor suppressor genes, and to develop targeted therapies for specific cancer types.

Immunotherapy is a new class of cancer treatment that harnesses the body's immune system to fight cancer cells. Recent research has focused on developing new immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cell therapy, which have shown promising results in the treatment of certain types of cancer. Single-cell sequencing is a technique that allows researchers to study the genetic and molecular profiles of individual cells. Recent research has focused on using single-cell sequencing to identify rare cell populations within tumors that may be responsible for driving cancer growth and to develop new therapies that target these cells.

Liquid biopsies are a non-invasive way to detect and monitor cancer. Recent research has focused on using liquid biopsies to identify biomarkers of cancer progression and response to treatment, as well as to develop new therapies that target these biomarkers. Artificial intelligence (AI) is a powerful tool for analyzing large amounts of data and identifying patterns that may be difficult to detect using traditional methods. Recent research has focused on using AI algorithms to analyze genomics and imaging data to identify new cancer drivers and develop personalized treatment strategies.

  • Cancer genetics
  • Cancer diagnostics
  • Cancer therapeutics
  • Cancer stem cells
  • Metastasis
  • Precision oncology

Related Conference of Hematology